Description
Rhinostop Pharmacodynamics
Vasoconstrictor for local use in ENT practice. Alpha-adrenomimetic. When applied to the mucous membranes it causes vasoconstriction, resulting in reduction of local hyperemia and edema. In rhinitis it facilitates nasal breathing.
Indications
Acute allergic rhinitis, sinusitis, pollinosis, otitis media (for reduction of nasopharyngeal mucous edema), preparation of the patient for diagnostic procedures in the nasal passages.
Contraindications
Closed-angle glaucoma, atrophic rhinitis, arterial hypertension, tachycardia, marked atherosclerosis, hyperthyroidism, brain surgery (in anamnesis), hypersensitivity to xylometazolin.
Dosage and administration method
It is used topically for 7-14 days. The dose depends on the used dosage form and age of the patient.
